- Home
- ORI vs CAI Comparison
ORI vs CAI Comparison
Compare ORI & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORI
- CAI
- Stock Information
- Founded
- ORI 1923
- CAI 2008
- Country
- ORI United States
- CAI United States
- Employees
- ORI N/A
- CAI N/A
- Industry
- ORI Property-Casualty Insurers
- CAI Medical Specialities
- Sector
- ORI Finance
- CAI Health Care
- Exchange
- ORI Nasdaq
- CAI Nasdaq
- Market Cap
- ORI 9.9B
- CAI 9.4B
- IPO Year
- ORI N/A
- CAI 2025
- Fundamental
- Price
- ORI $40.27
- CAI $34.06
- Analyst Decision
- ORI Buy
- CAI Strong Buy
- Analyst Count
- ORI 1
- CAI 6
- Target Price
- ORI $45.00
- CAI $35.50
- AVG Volume (30 Days)
- ORI 1.2M
- CAI 569.2K
- Earning Date
- ORI 10-23-2025
- CAI 11-12-2025
- Dividend Yield
- ORI 2.88%
- CAI N/A
- EPS Growth
- ORI 48.63
- CAI N/A
- EPS
- ORI 3.53
- CAI N/A
- Revenue
- ORI $8,666,400,000.00
- CAI $533,847,000.00
- Revenue This Year
- ORI $9.05
- CAI $59.70
- Revenue Next Year
- ORI $5.97
- CAI $50.34
- P/E Ratio
- ORI $11.42
- CAI N/A
- Revenue Growth
- ORI 14.20
- CAI 106.53
- 52 Week Low
- ORI $33.00
- CAI $25.40
- 52 Week High
- ORI $41.15
- CAI $42.50
- Technical
- Relative Strength Index (RSI)
- ORI 59.90
- CAI N/A
- Support Level
- ORI $39.46
- CAI N/A
- Resistance Level
- ORI $41.15
- CAI N/A
- Average True Range (ATR)
- ORI 0.56
- CAI 0.00
- MACD
- ORI -0.06
- CAI 0.00
- Stochastic Oscillator
- ORI 52.16
- CAI 0.00
About ORI Old Republic International Corporation
Old Republic International Corp offers a diverse range of specialized insurance products to individuals and institutions. The company operates in two segments: Specialty Insurance and Title Insurance. The Insurances provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others.
About CAI Caris Life Sciences Inc. Common Stock
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.